Rising development costs of biosimilars make US market entry difficult proposition

Published: 2010-11-01 07:00:00
Updated: 2010-11-01 07:00:00
Clearing the U.S. regulatory hurdles is expected to be an arduous exercise for Korean firms, said President Song Byung-doo of Scripps Korea Antibody Institute (SKAI).

In a local SKAI symposium, Song said that Biosimilar development is riddled with complexities, ranging from regulatory, to manu...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.